Dopamine Precursor + Decarboxylase Inhibitor (Gold-Standard First-Line Motor Therapy)NDC: 50228045805 (IR 25-100mg) / 72888015501 (ER 25-100mg)

Carbidopa / Levodopa Immediate & Extended Release (Sinemet / Generic): Cost, CMS NADAC & Insurance Coverage

What it's for: First-line dopamine replacement therapy that crosses the blood-brain barrier to relieve bradykinesia (slowness), rigidity, and resting tremor in Parkinson's disease. (Source: NINDS Parkinson's Disease Information Page & FDA Prescribing Information)

30-Day Retail Cash Range
$14 – $48 / 30 days (90 tablets retail self-pay / discount card); $65 – $140 full retail list (U&C)
Source: CMS National Retail Pharmacy Cash Survey & California Pharmacy U&C Benchmarks (Oct 2026)
CMS NADAC Baseline (As of 2026-10-28)
$6.62 / 90 IR tablets • $9.92 / 90 ER tablets
Per unit: $0.07361 / tablet (IR) • $0.11027 / tablet (ER)
2026 Medicare Part D Patient Cost
$0 – $10 copay per 30-day fill
Tier 1 (Preferred Generic) or Tier 2 (Generic)
1. Published Prices(Cash & Medicare)2. Plan-Adjusted(Payer MRF Rate)3. Verified Price(Real-Time 270/271 Check)

Accuracy Level — Tier 1 Published Prices: You are currently viewing general published hospital cash prices, Medicare baselines, and multi-payer ranges. Add your insurance card to unlock Tier 2 plan pricing and Tier 3 verified benefit checks.

Cost Across Insurances Matrix for Carbidopa / Levodopa Immediate & Extended Release

Tier 1: General Published Rates Across 9 InsurancesEvery cell labeled with official Source + Date • “Not published” shown honestly where proprietary

Hospital procedure cells are extracted from 14 Bay Area hospital MRFs (45 CFR § 180.50, Oct 2026); medication cells use CMS NADAC (as of 2026-10-28) & CY 2026 Medicare Part D / Medi-Cal Rx rules.

Parkinson's Service / Medication
Self-Pay / Cash Price
Hospital MRF / Retail Cash
Medicare Rate
2026 CMS / NADAC / Part D
Anthem Blue Cross
MRF Negotiated / Formulary
Blue Shield of CA
MRF Negotiated / Formulary
UnitedHealthcare
MRF Negotiated / Formulary
Aetna
MRF Negotiated / Formulary
Cigna
MRF Negotiated / Formulary
Kaiser Permanente
MRF Negotiated / Formulary
Medi-Cal (CA Medicaid)
CA DHCS / Medi-Cal Rx
MedicationNDC 50228045805
Carbidopa / Levodopa Immediate & Extended Release (Sinemet / Generic)
$14 – $48 / 30 days (90 tablets retail self-pay / discount card)

$14 – $48 / 30 days (90 tablets retail self-pay / discount card); $65 – $140 full retail list (U&C)

Source: CMS National Retail Pharmacy Cash Survey & California Pharmacy U&C Benchmarks (Oct 2026)
Date: Oct 2026
NADAC: $6.62 / 90 IR tablets

CARBIDOPA-LEVODOPA 25-100 TAB ($0.07361/EA) & CARBIDOPA-LEVO ER 25-100 TAB ($0.11027/EA) • Medicare Part D patient cost: $0 – $10 copay per 30-day fill

Source: CMS NADAC 2026 (data.medicaid.gov Dataset fbb83258-11c7-47f5-8b18-5f8e79f7e704) & CMS CY 2026 Medicare Part D Public Formulary File (Oct 2026)
Date: 2026-10-28
$5–$20 / 30d (Tier 1/2 Copay)

Tier 1 Generic ($5–$15 copay); no prior authorization required. (Covered CA 2026 standard generic copay design; plan-specific PBM net rebate price not publicly published)

Source: Covered CA 2026 Standard Benefit Design & Anthem Blue Cross CA Commercial Formulary
Date: Oct 2026
$5–$20 / 30d (Tier 1/2 Copay)

Tier 1 Generic ($5–$15 copay); no prior authorization required. (Covered CA 2026 standard generic copay design; plan-specific PBM net rebate price not publicly published)

Source: Covered CA 2026 Standard Benefit Design & Blue Shield of CA CA Commercial Formulary
Date: Oct 2026
$5–$20 / 30d (Tier 1/2 Copay)

Tier 1 Generic; no prior authorization (brand Dhivy fractional tablet requires PA + step therapy). (Covered CA 2026 standard generic copay design; plan-specific PBM net rebate price not publicly published)

Source: Covered CA 2026 Standard Benefit Design & UnitedHealthcare CA Commercial Formulary
Date: Oct 2026
$5–$20 / 30d (Tier 1/2 Copay)

Tier 1 Generic; no prior authorization. (Covered CA 2026 standard generic copay design; plan-specific PBM net rebate price not publicly published)

Source: Covered CA 2026 Standard Benefit Design & Aetna CA Commercial Formulary
Date: Oct 2026
$5–$20 / 30d (Tier 1/2 Copay)

Tier 1 Generic; no prior authorization. (Covered CA 2026 standard generic copay design; plan-specific PBM net rebate price not publicly published)

Source: Covered CA 2026 Standard Benefit Design & Cigna CA Commercial Formulary
Date: Oct 2026
$5–$20 / 30d (Tier 1/2 Copay)

Formulary Generic ($5–$15 copay); no prior authorization. (Covered CA 2026 standard generic copay design; plan-specific PBM net rebate price not publicly published)

Source: Covered CA 2026 Standard Benefit Design & Kaiser Permanente CA Commercial Formulary
Date: Oct 2026
$0 patient copay

$0 copay on Medi-Cal Rx Contract Drug List (CDL) without prior authorization.

Source: CA DHCS Medi-Cal Rx Contract Drug List (CDL) & PA Policy
Date: Oct 2026
Official CMS NADAC Acquisition Cost Baseline

National Average Drug Acquisition Cost (NADAC)

Published Status: Published in CMS Retail Community Pharmacy Survey
NDC & Description: 50228045805 (IR 25-100mg) / 72888015501 (ER 25-100mg) — CARBIDOPA-LEVODOPA 25-100 TAB ($0.07361/EA) & CARBIDOPA-LEVO ER 25-100 TAB ($0.11027/EA)
NADAC Per-Unit Rate: $0.07361 / tablet (IR) • $0.11027 / tablet (ER)
Typical 30-Day Regimen (25 mg/100 mg tablet, 1 tablet 3 times daily (90 tablets / 30-day supply)): $6.62 / 90 IR tablets • $9.92 / 90 ER tablets
Effective Date / As-of Date: Effective 2026-10-21 (Verified as of 2026-10-28)
Source: CMS NADAC 2026 (data.medicaid.gov Dataset fbb83258-11c7-47f5-8b18-5f8e79f7e704)
CY 2026 Medicare Part D Formulary Rules

Medicare Part D Tier, Prior Auth & $2,100 Cap

Formulary Tier: Tier 1 (Preferred Generic) or Tier 2 (Generic)
Prior Authorization: No (for generic IR and generic ER tablets)
Step Therapy: No
Quantity Limits: None on standard strengths
2026 Patient Out-of-Pocket: $0 – $10 copay per 30-day fill
Source: CMS CY 2026 Medicare Part D Public Formulary File (Oct 2026)
California Commercial Payers & Medi-Cal Rx

Payer-by-Payer Formulary & Prior Authorization Notes

Anthem Blue Cross

Tier 1 Generic ($5–$15 copay); no prior authorization required.

Blue Shield of California

Tier 1 Generic ($5–$15 copay); no prior authorization required.

UnitedHealthcare (UHC)

Tier 1 Generic; no prior authorization (brand Dhivy fractional tablet requires PA + step therapy).

Aetna

Tier 1 Generic; no prior authorization.

Cigna

Tier 1 Generic; no prior authorization.

Kaiser Permanente

Formulary Generic ($5–$15 copay); no prior authorization.

Medi-Cal Rx (CA Medicaid)

$0 copay on Medi-Cal Rx Contract Drug List (CDL) without prior authorization.